new IV immune globulin called RespiGam

March 1996

You'll see a new IV immune globulin called RespiGam...formulated to prevent Respiratory Syncytial Virus (RSV) disease in children.

RSV is the leading cause of pneumonia in infants. Those at highest risk are premature infants...and children under age two with lung disease.

RespiGam is given to these high-risk children once a month during the RSV season...November to April.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote